Emcure Pharmaceuticals Limited — Nitrofurantoin Exporter Profile
Indian Pharmaceutical Exporter · #4 for Nitrofurantoin · $2.2M export value · DGFT Verified
Emcure Pharmaceuticals Limited is the #4 Indian exporter of Nitrofurantoin with $2.2M in export value and 67 verified shipments. Emcure Pharmaceuticals Limited holds a 6.3% market share in Nitrofurantoin exports across 5 countries. The company exports 39 pharmaceutical products worth $147.8M across 19 therapeutic categories.
Emcure Pharmaceuticals Limited — Nitrofurantoin Export Profile: Buyers & Destinations
Where Does Emcure Pharmaceuticals Limited Export Nitrofurantoin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $995.4K | 23 | 54.1% |
| UNITED KINGDOM | $755.6K | 39 | 41.1% |
| SOUTH AFRICA | $77.4K | 2 | 4.2% |
| CHILE | $11.7K | 2 | 0.6% |
| MALTA | $5 | 1 | 0.0% |
Emcure Pharmaceuticals Limited exports Nitrofurantoin to 5 countries. The largest destination is AUSTRALIA accounting for 54.1% of Emcure Pharmaceuticals Limited's Nitrofurantoin shipments, followed by UNITED KINGDOM (41.1%) and SOUTH AFRICA (4.2%). These destinations reflect Emcure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Nitrofurantoin from Emcure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TILLOMED LABORATORIES LTD | UNITED KINGDOM | $646.0K | 25 |
| ARROTEX PHARMACEUTICALS PTY LTD | AUSTRALIA | $404.3K | 10 |
| ARROW PHARMACEUTICALS PTY LTD | AUSTRALIA | $327.9K | 7 |
| LUMINARIE PTY LTD | AUSTRALIA | $138.2K | 3 |
| ARROTEX PHARMACEUTICALS PTY LIMITED | AUSTRALIA | $100.0K | 2 |
| TILLOMED LABORATORIES LTD. | UNITED KINGDOM | $80.3K | 12 |
| EMCURE PHARMACEUTICALS SA PTY LTD | SOUTH AFRICA | $77.4K | 2 |
| TILLOMED LABORATORIES LIMITED | UNITED KINGDOM | $29.3K | 1 |
| LUMINARIE PTY.LTD. | AUSTRALIA | $25.1K | 1 |
| EMCURE PHARMA CHILE S P A | CHILE | $11.7K | 1 |
Emcure Pharmaceuticals Limited supplies Nitrofurantoin to 13 buyers globally. The largest buyer is TILLOMED LABORATORIES LTD (UNITED KINGDOM), followed by ARROTEX PHARMACEUTICALS PTY LTD (AUSTRALIA) and ARROW PHARMACEUTICALS PTY LTD (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Nitrofurantoin Export Value and How Much Does Emcure Pharmaceuticals Limited Contribute?
India exported $20.2M worth of Nitrofurantoin through 1,809 shipments from 199 suppliers to 92 countries, serving 317 buyers globally. Emcure Pharmaceuticals Limited contributes $2.2M to this total, accounting for 6.3% of India's Nitrofurantoin exports. Emcure Pharmaceuticals Limited ships Nitrofurantoin to 5 countries through 13 buyers.
What Is the Average Shipment Value for Emcure Pharmaceuticals Limited's Nitrofurantoin Exports?
Emcure Pharmaceuticals Limited's average Nitrofurantoin shipment value is $32.3K per consignment, based on 67 shipments totaling $2.2M. The largest destination is AUSTRALIA (54.1% of Emcure Pharmaceuticals Limited's Nitrofurantoin exports).
How Does Emcure Pharmaceuticals Limited Compare to Other Indian Nitrofurantoin Exporters?
Emcure Pharmaceuticals Limited ranks #4 among 199 Indian Nitrofurantoin exporters with a 6.3% market share. The top 3 exporters are MANKIND PHARMA LIMITED ($10.1M), EMCURE PHARMACEUTICALS LIMITED ($2.2M), RECIPHARM PHARMASERVICES PRIVATE LIMITED ($1.2M). Emcure Pharmaceuticals Limited processed 67 shipments to 5 destination countries.
What Nitrofurantoin Formulations Does Emcure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ARX-NITROFURANTOIN 100MG CAPSULE 3X10 (N | $200.0K | 4 |
| PHARMACEUTICALS PRODUCTS ( FINISHED PRODUCT) (GENERIC NAME) ARX-NITROFURANTOIN 50 MG CAPSULE 3X10 | $186.2K | 4 |
| PHARMACEUTICALS PRODUCTS ( FINISHED PRODUCT) (GENERIC NAME) ARX-NITROFURANTOIN 100 MG CAPSULE 3X10 | $177.9K | 4 |
| ARX-NITROFURANTOIN 50MG CAPSULE 3X10 (NI | $177.7K | 4 |
| PHARMACEUTICALS ARTICLE / ODS / PRODUCT / ITEM FINISHED PRODUCTARX-NITROFURANTOIN 100 MG CAPSULE 3X10 | $100.0K | 2 |
| PHARMACEUTICALS PRODUCTS ( FINISHED PRODUCT) ARX-NITROFURANTOIN 100 MG CAPSULE 3X10 | $84.1K | 3 |
| PHARMACEUTICALS PRODUCTS ( FINISHED PRODUCT) ARX-NITROFURANTOIN 100 MG CAPSULE 3X10 ( NITROFURANTOIN CAPSULES 100 MG ) | $69.4K | 2 |
| PHARMACEUTICALS PRODUCTS FINISHED PRODUCT Generic Name NITROFURANTOIN 100MGCAPSULE 5X10 NITROFURANTOIN CAPSULES | $46.9K | 1 |
| NITRO 50MG CAPSULE 3X10 CAP EACH CAPSULE CONTAINS NITROFURANTOIN MACROCRYSTALS 50MG BATCH NO H230174 | $40.9K | 1 |
| NITRO 50MG CAPSULE 3X10 CAP EACH CAPSULE CONTAINS NITROFURANTOIN MACROCRYSTALS 50MG BATCH NO H230175 | $40.8K | 1 |
Emcure Pharmaceuticals Limited exports 43 distinct Nitrofurantoin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ARX-NITROFURANTOIN 100MG CAPSULE 3X10 (N with 4 shipments worth $200.0K.
Regulatory Requirements: Exporting Nitrofurantoin to Key Markets
What Emcure Pharmaceuticals Limited must comply with to export Nitrofurantoin to its top destination countries
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Emcure Pharmaceuticals Limited Compare to Nearest Nitrofurantoin Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MANKIND PHARMA LIMITED | $10.1M | 201 | 1 | $50.0K |
| 4 | EMCURE PHARMACEUTICALS LIMITED ★ | $2.2M | 67 | 5 | $32.3K |
| 6 | RECIPHARM PHARMASERVICES PRIVATE LIMITED | $1.2M | 26 | 1 | $44.5K |
| 7 | MANKIND PHARMA LTD | $1.1M | 24 | 1 | $44.9K |
Emcure Pharmaceuticals Limited ranks #4 among 199 Indian Nitrofurantoin exporters. Average shipment value of $32.3K compared to the market average of $101.4K. The closest competitors by value are MANKIND PHARMA LIMITED and RECIPHARM PHARMASERVICES PRIVATE LIMITED.
Which Indian Ports Ship Nitrofurantoin Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 264 | 14.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 238 | 13.2% |
| SAHAR AIR | 208 | 11.5% |
| DELHI AIR | 197 | 10.9% |
| NHAVA SHEVA SEA (INNSA1) | 128 | 7.1% |
| JNPT/ NHAVA SHEVA SEA | 93 | 5.1% |
| Bombay Air | 75 | 4.1% |
| Delhi Air | 71 | 3.9% |
What Other Advanced Antibiotics Products Does Emcure Pharmaceuticals Limited Export?
Emcure Pharmaceuticals Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Emcure Pharmaceuticals Limited's Nitrofurantoin Exports
Emcure's extensive export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic adjustments in logistics and supply chain management to mitigate potential delays and cost escalations.
Conversely, the ongoing US-China trade tensions have opened opportunities for Indian pharmaceutical companies like Emcure to expand their footprint in the US market. The US's inclination to diversify its supply chain away from China presents a favorable environment for Indian exporters to increase their market share.
In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, impose additional compliance requirements on exporters. Emcure's adherence to these regulations is crucial for maintaining and expanding its presence in the EU market.
Emcure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Emcure's export operations. The company has consistently met the Good Manufacturing Practice (GMP) requirements set by the FDA, WHO, and EU authorities. However, the evolving regulatory landscape demands continuous investment in quality assurance and compliance mechanisms to ensure uninterrupted market access.
Recent incidents, such as the brief shutdown of the Pune plant due to a fire, highlight the importance of robust risk management and compliance strategies to maintain operational continuity and regulatory adherence. (tipranks.com)
About Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited exports 39 products worth $147.8M. Beyond Nitrofurantoin, top products include Dolutegravir, Mycophenolate, Tenofovir, Iron, Melphalan. View the complete Emcure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Nitrofurantoin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Nitrofurantoin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Emcure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 67 individual customs records matching Emcure Pharmaceuticals Limited exporting Nitrofurantoin, covering 43 formulations to 5 countries via 13 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 92+ countries, 317+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Nitrofurantoin Export Data from Emcure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Emcure Pharmaceuticals Limited's Nitrofurantoin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Emcure Pharmaceuticals Limited
Full Company Profile →
39 products · $147.8M total trade · 19 categories
Nitrofurantoin Stats
Company Overview
Top Products by Emcure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Emcure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Nitrofurantoin. For current shipment-level data, contact TransData Nexus.